Loading...
XTAI
1720
Market cap365mUSD
Dec 05, Last price  
64.00TWD
1D
-0.78%
1Q
13.07%
Jan 2017
96.32%
Name

Standard Chem & Pharm Co Ltd

Chart & Performance

D1W1MN
XTAI:1720 chart
P/E
12.99
P/S
1.68
EPS
4.93
Div Yield, %
4.22%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
11.51%
Revenues
6.79b
+8.81%
1,924,414,0002,011,721,0002,182,198,0002,284,616,0002,894,482,0003,332,008,0003,373,811,0003,053,983,0003,295,656,0003,321,366,0003,673,801,0003,848,684,0003,573,093,0003,937,129,0004,305,400,0004,604,082,0005,851,368,0006,239,768,0006,789,223,000
Net income
881m
+5.46%
323,443,000267,715,000274,597,000293,463,000210,053,000246,748,000271,426,000298,386,000374,235,000347,894,000340,216,000363,286,000374,359,000376,482,000524,172,000706,734,0001,153,620,000834,886,000880,501,000
CFO
1.69b
+26.82%
358,745,000323,595,000719,169,000634,227,000272,474,000405,494,000402,246,000427,259,000582,305,000650,865,000305,376,000708,738,000484,935,000637,939,000922,580,000827,034,0001,227,834,0001,336,523,0001,694,941,000
Dividend
Aug 01, 20242.7 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.
IPO date
Dec 12, 1995
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT